Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: john jansen who wrote (357)	5/21/1998 12:29:00 AM
From: JEFF CHAPMAN	Read Replies (2) \| Respond to of 705

Welcome to the world of momentum day trading, dude. Right now it IS the in thing, it all started out w/ KTEL (a subject I created on SI)... I never short stocks, only go long, fwiw. Besides, look at all the exposure your company is getting. All the investment bankers, news services, etc. are looking at the stock... Will be good when NEOT needs financing for PH III trials...

To: john jansen who wrote (357)	5/21/1998 2:03:00 AM
From: Nikole Wollerstein	Read Replies (2) \| Respond to of 705

Very strange news : AIT-082 is expected to induce nerve growth factor (NGF)that is increase amount of b-amiloid peptide - the cause of Alzheimer disease. It was as I understand the biggest question about AIT function as anti Alzheimer agent. The I stage trial, as I remember included old patient not affected by Alzheimer, so mentioned memory improvement, though encouraging have nothing to do with the disease and does not and much to our knowledge abut AIT-082 The market for drugs that prevent development of debilitating diseases besides Alzheimer still huge, and news still sound positive, but, honestly, I am very confused: this information was available 3 weeks ago( I spoke to IR) and stock did not moved until today.